Navigation Links
Accuri Cytometers Completes $13 Million Series C Financing
Date:7/8/2008

ing flow cytometers in an easy-to-use format and at a fraction of their cost. The Accuri system was engineered from the start to be compact, powerful and user-friendly, while also being affordable by most research laboratories. For more information, visit http://www.accuricytometers.com.

About Fidelity Biosciences

Fidelity Biosciences is a division of Devonshire Investors, which invests private equity on behalf of Fidelity Investments. For more than 30 years, the firm has had a significant presence in the venture capital and private equity industry. This provides Fidelity Biosciences with the flexibility, and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value. For more information, please visit http://www.fidelitybiosciences.com.

About Flagship Ventures

Flagship Ventures is a venture capital firm focused on creating, financing and building innovative companies. Founded in 2000, Flagship manages over $600 million in early-stage funds and operates from its offices at Kendall Square in Cambridge, MA. With an active portfolio of over 40 companies, the firm's strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: Adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, Helicos Biosciences, Hypnion, IDEXX, Morphotek, PerSeptive Biosystems and TripAdvisor. For more information please visit http://www.flagshipventures.com.

About Baird Venture Partners
'/>"/>

SOURCE Accuri Cytometers Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)
2. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
3. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
4. EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
5. Boston Scientific Completes Acquisition of CryoCor
6. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
7. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
8. SynCo Bio Partners Completes Manufacture and Release of ActoGeniX Lead Product for Phase II Clinical Trials
9. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
10. China-Biotics, Inc. Completes Foundation for Its New Plant
11. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 PAREXEL ... global clinical research organization , announced ... definitive agreement to acquire all of the ... a leading provider of specialized pharmacovigilance services, ... the collection, detection, assessment, monitoring, and prevention ...
(Date:3/26/2015)... 2015 WriteResult, a premier provider of ... Yale University’s School of Public Health and New Haven ... a 4 month-long project. The goal of the study ... families with free access to fresh produce and nutrition ... concerns like high blood pressure, diabetes and weight gain. ...
(Date:3/25/2015)... 2015 Optimal Research, LLC has been nominated ... Award "Best Clinical Site or Trial Network". ... been selected as a nominee in this ViE award ... Recommended" distinction in 2014. The ViE awards were created ... and positive contributions of companies and individuals in the ...
(Date:3/25/2015)... Accelovance, a therapeutically focused contract research organization ... Research Organization" at the upcoming Vaccine Industry Excellence (ViE) ... This is the eighth consecutive year Accelovance has ... for "Best Contract Research Organization" in 2009, 2010, and ... "We,re excited to be a finalist for ...
Breaking Biology Technology:PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award 2Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2
... , WALTHAM, Mass., Dec. 14 Lionbridge (Nasdaq: ... a new, three-year master services agreement with a multi-billion ... patients in approximately 100 countries. With the agreement Lionbridge ... company,s online content, which includes regulatory, marketing, training, human ...
... Dec. 11 EntreMed, Inc. (Nasdaq: ENMD ), today ... sales of Thalomid® during the third quarter compared to estimated ... anticipates a decrease in fourth quarter and projected revenue for ... for the third quarter will be reflected in the fourth ...
... , SAN DIEGO, Dec. 11 ... University of Texas M. D. Anderson Cancer Center of the first patient ... fficacy) Phase 2 pivotal trial in patients with relapsed or refractory ... and highly selective small molecule that was specifically designed as a FMS-like ...
Cached Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/11/2015)... and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has announced ... Product, Application & By Geography - Global Forecast & ... This report predicts that the access control ... with an estimated CAGR of 10.6%. The ... as contact cards & readers, contactless cards & readers, ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
... (Garrison, NY) As government support for personalized medicine ... ethical controversies. Direct-to-consumer genetic tests, privacy, targeted cancer therapies, ... issue of the Hastings center Report ... medicine the use of genetic information to individualize ...
... (September 15, 2010) BioSpace and BioMed Central ... Career Network today, a new online community for ... and industry news. The new Career Network ... with open access publisher BioMed Central,s 1.2 million ...
... Scientists at UC Santa Barbara have discovered a caste ... parasitic fluke species that invades the California horn snail. ... of the Proceedings of the Royal Society B ... vicious, killer morphs defending the colony," said Armand M. ...
Cached Biology News:With growing US support for personalized medicine, a look at ethical dilemmas 2'Warrior worms' discovered in snails; UCSB scientists see possible biomedical applications 2
Without sodium bicarbonate. Sterile, Cell culture tested...
... Bioactive peptides are molecules of peptidic nature ... or activity which can be developed at ... and agro-food applications. In this way it ... superior properties for therapeutic applications. Primm offers ...
... is a fluorescence scanner with 1 or ... Packing, Protein, CGH, ) spotted on standard ... of InnoScan700 scanners include three different models:, ... a simultaneous dual fluorescence scanner (635nm and ...
... neurons in vesicles called synaptosomes. ... bouton. Synaptosomes may be centrifuged ... cellular debris. Abnormalites in neurotransmitter release ... condtions. Conditions of release may ...
Biology Products: